UGT1A6 and adenoma: One of the genes downregulated during the adenoma-carcinoma progression is UGT1A6. As the wild-type allele has lower metabolic activity compared to the variant allele, participants with wild-type genotype are likely to retain active metabolites of aspirin longer than the mutant allele carriers; hence, deriving greater chemopreventive benefit.